Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zahrieh

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
JNCI Cancer Spectrum|January 17, 2024
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1)Ellen M Lavoie Smith, Youmin Cho, Shauna Hillman, et al.
BMJ Open|November 17, 2022
Increasing socioeconomically disadvantaged patients' engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trialJessica R Schumacher, David Zahrieh, Selina Chow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
Costs of allogeneic hematopoietic cell transplantation with high-dose regimensAkiko M Saito, Corey Cutler, David Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
Trials|October 12, 2023
Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocolJoannie Ivory, Stephanie B Wheeler, Sarah Drier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunctionGullu Gorgun, Alan G Ramsay, Tobias A W Holderried, et al.
Cancer|March 27, 2007
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trialPalma Dileo, Jeffrey A Morgan, David Zahrieh, et al.
Cancer Medicine|April 5, 2023
A five arm natural history study of nasal vestibulitisElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2021
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) studyElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
American Journal of Hematology|February 7, 2013
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 studyDerlis E Gonzalez, Hadhami Ben Turkia, Elena A Lukina, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
JNCI Cancer Spectrum|January 17, 2024
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1)Ellen M Lavoie Smith, Youmin Cho, Shauna Hillman, et al.
BMJ Open|November 17, 2022
Increasing socioeconomically disadvantaged patients' engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trialJessica R Schumacher, David Zahrieh, Selina Chow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
Costs of allogeneic hematopoietic cell transplantation with high-dose regimensAkiko M Saito, Corey Cutler, David Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
Trials|October 12, 2023
Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocolJoannie Ivory, Stephanie B Wheeler, Sarah Drier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunctionGullu Gorgun, Alan G Ramsay, Tobias A W Holderried, et al.
Cancer|March 27, 2007
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trialPalma Dileo, Jeffrey A Morgan, David Zahrieh, et al.
Cancer Medicine|April 5, 2023
A five arm natural history study of nasal vestibulitisElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2021
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) studyElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
American Journal of Hematology|February 7, 2013
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 studyDerlis E Gonzalez, Hadhami Ben Turkia, Elena A Lukina, et al.
Pageof 9